| Lorazepam Leman 2.5 mg, comprimés - 50 | | 70235012 | | Leman SKL SA | | Lorazepam Leman 2.5 mg, comprimés | | 18.12.2025 | | | | | 18.12.2025 | | Lorazepam (N05BA06) | | | | DDD-OMS | | 17.12.2030 | | | | 50 | | 01.04.10. | | | | | | | | Non | | | | | | | | | | | | N.O. | | | | FB | | | | 7680702350127 | | Synthetika | | | | |
| | Composition | | lorazepamum 2.5 mg, lactosum monohydricum 120 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, magnesii stearas, pro compresso corresp. natrium 0.25 mg. | | Packungsbestandteile | | Comprimés | | | | Principe actif | Concentr. |
|---|
| Lorazepam | 2.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | Lactose Monohydrate | 120 mg | | Magnesii Stearas | | | Pro Compresso | |
|
| | Source | | | |
|
|